Deacetylnemorone Abietane Diterpenoids for Use in Cancer Treatment
AssigneeUniversity of South Carolina
InventorsEHSAN JABBARZADEH, WESLEY F. TAYLOR, SARA ESLAMBOLCHI MOGHADAM
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of South Carolina
InventorsEHSAN JABBARZADEH, WESLEY F. TAYLOR, SARA ESLAMBOLCHI MOGHADAM
Estimating the term…
A deacetylnemorone abietane diterpenoid is utilized in the prevention of growth and development of pathogenic cells, e.g., cancer cells. The deacetylnemorone can have the following structure: or a tautomer there of in which R1, R2, and R3 are independently selected from —H, C1-10 alkyl, C1-10 alkoxy, C1-10 alkenyl, C1-10 alkenoxy, —OH, —OAc, —CHO, -Ph, —OC6H5, —OC6H4OH, —COC6H5, —OCONH2, —OCONHCH3, —OCOC6H4NH2, —NH2, or ═O. The deacetylnemorone shows efficacy in treatment and prevention of a wide range of cancer types, as well as other neoplastic diseases as a chemo-preventative, a primary or secondary cytotoxic agent, a sensitizer for other therapies, or one component of a combinatorial treatment.
A method for inhibiting angiogenesis, the method comprising delivering a deacetylnemorone abietane diterpenoid to an area comprising endothelial cells.
A composition comprising a deacetylnemorone abietane diterpenoid and a pharmaceutically compatible carrier, the deacetylnemorone abietane diterpenoid having the following structure:
Dependencies are inferred from the claim text.